Is Pfizer Preparing for a Rebound? | Technical Analysis

The Pfizer Inc. stock (NYSE: PFE) traded in a consolidative manner the last few days, staying slightly above the upside support line drawn from the low of March 23rd. As long as the stock stays above that line, we would see decent chances for a rebound, but we would start examining such a case only if we see a break above the peak of December 24th, at 37.60.

As we already noted, a break above 37.60 may confirm a potential rebound in this stock, and may initially pave the way towards the inside swing low of December 3rd, at 39.55. If investors are not willing to stop there, then the next barrier to consider as a resistance may be the 41.40 zone, marked by the highs of November 9th and December 2nd. Another break, above 41.40, could pave the way towards the 43.20 hurdle, which is fractionally above the peak of December 9th, and is marked by the low of July 29th, 2019.

Taking a look at our daily oscillators, we see that the RSI lies slightly below 50 but points up, while the MACD, although negative, has bottomed and moved back above its trigger line. Both indicators detect diminishing downside speed, which enhances the case for a potential rebound soon.

In order to start examining the case of larger declines, we would like to see a dip below 35.85, marked by the lows of November 17th and 19th. The price would already be below the aforementioned upside line, and we may thereby see declines towards the low of October 29th, at 34.60. If that level is not able to halt the slide, its break may set the stage for the 33.10 barrier, marked by the low of July 9th, the break of which may carry extensions towards the low of June 26th, at 31.60.


The content we produce does not constitute investment advice or investment recommendation (should not be considered as such) and does not in any way constitute an invitation to acquire any financial instrument or product. The Group of Companies of JFD, its affiliates, agents, directors, officers or employees are not liable for any damages that may be caused by individual comments or statements by JFD analysts and assumes no liability with respect to the completeness and correctness of the content presented. The investor is solely responsible for the risk of his investment decisions. Accordingly, you should seek, if you consider appropriate, relevant independent professional advice on the investment considered. The analyses and comments presented do not include any consideration of your personal investment objectives, financial circumstances or needs. The content has not been prepared in accordance with the legal requirements for financial analyses and must therefore be viewed by the reader as marketing information. JFD prohibits the duplication or publication without explicit approval.

There are risks involved with trading of cash equities. Past performance is not indicative of future results. You should consider whether you can tolerate such losses before trading. Please read the full Risk Disclosure.

Copyright 2021 JFD Group Ltd.